Sanofi, drugmaker behind Zantac, has agreed to settle 4,000 lawsuits The suits claim that discontinued Zantac contained cancer-causing chemicals READ MORE: Has heartburn pill that has been given ...

which alleged that the pharmaceuticals company defrauded the US government by concealing the cancer risks of heartburn drug Zantac for decades. GSK has not admitted any liability in either settlement.

An Illinois woman could be awarded $640million in damages from the makers of heartburn drug Zantac — as she claims the pill she took for 18 years caused her deadly colon cancer. In a landmark ...

Recently, the heartburn medicine Zantac, also known by its generic name ranitidine, has received pushback from the Food and Drug Administration after it was found to contain potentially high ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been ... product for indications like heartburn and acid indigestion – has been named as a defendant in ...

Urgent warnings have been issued over a popular heartburn medication, with fears it could contain a chemical linked to cancer risk. Zantac and its generic equivalents containing ranitidine could be a ...

For those who struggle with heartburn, ranitidine drugs like Zantac can be used for relief. However, after, high levels of a chemical previously known to have been used in rocket fuel were found ...